Frontier in Medical & Health Research
RNA M⁵C MODIFICATION LANDSCAPE: NSUN–TET–YBX/ALYREF AXIS AS A UNIVERSAL REGULATOR OF VIRAL INFECTION AND HOST IMMUNITY
PDF

Keywords

RNA modification; Viral infection; Host immunity; Anti viral Transcription; Biomarkers

How to Cite

RNA M⁵C MODIFICATION LANDSCAPE: NSUN–TET–YBX/ALYREF AXIS AS A UNIVERSAL REGULATOR OF VIRAL INFECTION AND HOST IMMUNITY. (2025). Frontier in Medical and Health Research, 3(10), 513-527. https://fmhr.net/index.php/fmhr/article/view/1759

Abstract

RNA 5‑methylcytosine (mC) is a pervasive epitranscriptomic mark that regulates RNA stability, translation, splicing, and nuclear export across coding and noncoding RNAs. A functional axis comprising NSUN methyltransferases (writers), TET dioxygenases (putative editors/oxidizers), and YBX1/ALYREF (readers/export factors) has emerged as a coherent framework to explain how mC dynamically shapes viral infection and host immunity. In this study, we synthesize recent evidence implicating NSUN2/NSUN6 in mRNA and viral RNA methylation, ALYREF in mC‑dependent mRNA export, YBX1 in mC‑dependent RNA stabilization, and TET enzymes in RNA mC oxidation to hmC, with context‑dependent effects on RNA fate and immune visibility.

We conducted a comprehensive literature review of peer‑reviewed studies and multi‑omics resources (2014–2025) across PubMed, Nature Research journals, Frontiers, PLOS, and NAR databases, prioritizing work that maps mC sites, manipulates axis components, and interrogates viral/immune phenotypes. Inclusion emphasized orthogonal validation (e.g., RNA bisulfite‑seq, LC‑MS/MS, CLIP/RIP‑seq), genetic perturbations, and in vivo infection models.

Key findings indicate that NSUN2‑driven mC enhances replication of HBV, HCV, SARS‑CoV‑2, and EV71, often via increased RNA stability/translation and ALYREF‑mediated export; conversely, NSUN2 depletion can heighten type I interferon responses through altered noncoding RNAs and RIG‑I signaling. According to new research, TET2-dependent oxidation of RNA m–C may have implications for antiviral transcriptional programs by modifying chromatin through RNA–protein circuits. Therapeutically, blocking YBX1/ALYREF interactions or modifying NSUN2/TET activity may reduce viral replication or recalibrate immune responses; m²C signatures may function as biomarkers of treatment response or infection severity. 

Conclusively the NSUN–TET–YBX/ALYREF axis is a universal regulator of interactions between viruses and their hosts.. Future work should prioritize standardized mC mapping, time‑resolved infection models, and translational studies to validate targets and optimize intervention strategies.

PDF